Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
investigation
Pharma
BMJ finds more irregularities in trial data for AZ's Brilinta
Fourteen years after AstraZeneca’s Brilinta reached the market, the data that backed its original approvals has been called into question.
Kevin Dunleavy
Jun 23, 2025 11:33am
France suspends use of Valneva chikungunya shot in older adults
Apr 28, 2025 10:35am
Trump administration launches pharma tariff investigation
Apr 15, 2025 10:40am
Senate probe slams Pfizer over alleged tax-dodging maneuvers
Mar 28, 2025 10:14am
AstraZeneca logs China sales decline in Q4 amid probes
Feb 6, 2025 10:31am
What can AZ's China probes teach other biopharma companies?
Dec 27, 2024 3:00am
